9.96 USD
↘ 0.32 (3.11%)LIVE (AS OF 11:27 AM EST)
Cullinan Therapeutics, Inc. Common Stock (CGEM) is currently trading at $9.96. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Nov 13, 2026.